Registered Nurse in Dexter, NM Accepting Medicare
2 Registered Nurse nurses found. Showing 1 - 2
 Vicki Waltrip, RN Registered Nurse - Wound Care Medicare: Not Enrolled in Medicare Practice Location: 9 Richmond Rd, Dexter, NM 88230 Phone: 575-910-1750 |
Sharon White, Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 100 N Lincoln, Dexter, NM 88230 Phone: 575-734-5420 |
News Archive
Blog reports on PPP aimed at improving health status of poorest Central Americans, Mexicans
"At the Inter-American Development Bank's (IDB) recent annual meeting in Panama, the two richest men in the world" - Mexican businessman and philanthropist Carlos Slim and Bill Gates, co-chair of the Bill & Melinda Gates Foundation – "discussed their contributions to a little-known public-private partnership that aims to improve the health status of the poorest Central Americans and Mexicans - Salud Mesoamerica 2015 or SM2015," Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), writes in the center's "Global Health Policy" blog.
Alizé Pharma obtains exclusive worldwide rights to develop new therapy for bone diseases
Alizé Pharma III SAS, an Alizé Pharma group company specialized in the development of biopharmaceuticals to treat metabolic disorders and rare diseases, today announces that it has acquired exclusive worldwide rights to develop and commercialize a new family of peptides with bone anabolic properties.
Celgene International Sàr presents PALACE 3 phase III results of apremilast in psoriatic arthritis at EULAR
Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (NASDAQ: CELG), today announced results from PALACE 3, the Company's third phase III study in psoriatic arthritis (PsA), at EULAR, the European Congress of Rheumatology annual meeting in Madrid, Spain.
FDA grants Acceleron's ACE-031 orphan designation for treatment of DMD
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
› Verified 8 days ago